Published: July 20, 2020 at 4:13 a.m. ET Shares of Enzymatica ENZY, +63.70% jumped 67% in Stockholm as the company said preliminary results show the ability of the mouth spray ColdZyme, in vitro, to deactivate SARS-CoV-2, the virus causing the COVID-19 pandemic. The study demonstrated that ColdZyme deactivates SARS-CoV-2 coronavirus by 98.3%, the company said.…
You don't have permission to access "http://www.medpagetoday.com/neurology/dementia/122675" on this server. Reference #18.c86ccd17.1787173315.eb6f329 https://errors.edgesuite.net/18.c86ccd17.1787173315.eb6f329
Connecting people with clinical trials is complicated — even if people identify a promising match, there’s a slew of potentially thorny factors, including geographic incompatibility, and financial and time considerations. Simply finding an appropriate trial can present an enormous hurdle. In a recent online survey of more than 2,000 adults, 71% of patients with chronic
Peter Muller 5 min read FOR TOO MANY guys, back muscles like the lats and traps get short shrift in training. Not on purpose, of course—after all, who doesn’t want a back that turns heads from behind or fills out a t-shirt like it’s stretched over a Greek statue—but since you can’t see those muscles